Effective management of Helicobacter pylori is essential for resolving peptic ulcer disease and preventing recurrence and gastric malignancy. Pharmacological Treatment of H. Pylori Related Peptic Ulcer Disease offers clinicians an in-depth review of current therapeutic strategies, including first-line regimens, resistance management, and patient adherence techniques. This course is ideal for providers seeking to enhance treatment outcomes through evidence-based pharmacologic approaches. Enroll today to stay updated on clinical guidelines and optimize care for patients with H. pylori–associated gastrointestinal conditions.